Početna › Mijelofibroza › Florida › Miami
Kliničke studije za Mijelofibroza u gradu Miami, FL
10 studija za Mijelofibroza traži sudionike na lokacijama u gradu Miami i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
U tijeku regrutacijaFaza 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
U tijeku regrutacijaFaza 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
U tijeku regrutacijaFaza 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
U tijeku regrutacijaFaza 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
U tijeku regrutacijaFaza 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
U tijeku regrutacijaFaza 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
U tijeku regrutacijaFaza 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
U tijeku regrutacijaFaza 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
U tijeku regrutacijaFaza 3
- University of Miami, Miami
Studije za Mijelofibroza u drugim gradovima
- Houston, TX19 studija
- New York City, NY18 studija
- Boston, MA12 studija
- Durham, NC12 studija
- Columbus, OH11 studija
- Seattle, WA11 studija
- Salt Lake City, UT10 studija
- Nashville, TN9 studija
- Cleveland, OH9 studija
- Tampa, FL9 studija
- Atlanta, GA9 studija
- Baldwin Park, CA9 studija
Ostale studije u gradu Miami
- Rak dojke42 studija
- Rak (sve vrste)36 studija
- Nemikrocelularni karcinom pluća31 studija
- Rak prostate27 studija
- Debljina27 studija
- Akutna mijeloična leukemija24 studija
- Metastatski karcinom24 studija
- Rak jajnika23 studija
- Prekomjerna tjelesna masa23 studija
- Multipli mijelom21 studija
- Ulcerativni kolitis21 studija
- Alzheimerova bolest20 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.